Skip to main content

Table 2 Mutational and biochemical features of ‘NP-C uncertain’ patients with only one NPC1 mutation

From: Assessment of plasma chitotriosidase activity, CCL18/PARC concentration and NP-C suspicion index in the diagnosis of Niemann-Pick disease type C: a prospective observational study

Patient ID

Variant allele 1 amino acid

Variant allele 1 reference

CCL18/PARC

ng/mL

ChT (dup24)

nmol/mL.h

NP-C SI score

Filipin staining

MLPA

7-KC

ng/mL

Clinical form

Period 1

NPC1B

p.(Leu846Pro)

New

233

109 (Neg)

55

Variant

Negative

134

Adult

NPC2B

p.(Phe1221Sfs*20)

[30]

123

53 (Neg)

60

Classical

Negative

34

Adult

NPC3B

p.(Gln775Pro)

[32]

198

167 (Neg)

55

Classical

Negative

<2

Adult

Period 2

NPC4B

p.(Arg1274Trp)

New

ND

ND

NC (<4 y.o.)

Variant

Negative

ND

Early infantile

NPC5B

p.(Glu451Lys)

[36]

550

771 (Neg)

NC (<4 y.o.)

Variant

Negative

258

Early infantile

NPC6B

p.(Asn222Ser)

[34]

138

59 (Neg)

NC (<4 y.o.)

Variant

Negative

150

Late infantile

NPC7B

p.(Gln775Pro)

New

416

132 (Neg)

101

Variant

Negative

125

Adult

NPC8B

p.(Gln775Pro)

[32]

39

24 (Neg)

120

Variant

Negative

19

Juvenile

  1. Mutations were described according to the latest HGVS recommendations (http://www.hgvs.org/mutnomen); ChT chitotriosidase (ChT activity of heterozygous individuals [dup24] multiplied by two), NC not conducted (patient <4 years old), ND no data available, Neg negative, 7-KC 7-ketocholesterol, LOD limit of detection (=2 ng/mL)